About Douglas Hay
Douglas Hay is CEO and CSO, director at Allinaire Therapeutics.
Experience
This experience comes from Douglas Hay's profile and from SEC filings. For roles taken from filings, the years are when the filings name Douglas Hay in the role, so the role may have started earlier or lasted longer.
Allinaire Therapeutics Inc. Current
CEO and CSO, director
2021 – Present · Cleveland, OH
Develops antibody treatments for people with pulmonary arterial hypertension.
HL
Hay Drug Discovery Consulting, LLC Current
President
2009 – Present
GP
Galleon Pharmaceuticals
Senior Vice President
2007 – 2009
GS
GSK
Vice President
1985 – 2007
Key Colleagues at Startups
The people Douglas Hay works with at each company, as listed on that company's latest Form D.
Allinaire Therapeutics Inc. · Form D, Apr 14, 2026